Canadian audio manufacturer Paradigm has announced its latest speaker lineup, the Premier Series v2. Vowing to set "a new standard for affordable high-performance audio", the new range consists of six ...

Paradigm is a Canadian (Toronto-based) hi-fi manufacturer that has been making high-performance loudspeakers since the early ’80s. In 2018, the company introduced the Premier Series, an affordable ...

Paradigm Premier Series v2 arrives at AXPONA 2026 with six new models, upgraded driver technology, and pricing aimed at affordable high performance. Toronto-based Paradigm is debuting its Premier ...

Adam Benjamin has helped people navigate complex problems for the past decade. The former digital services editor for Reviews.com, Adam now leads CNET's services and software team and contributes to ...

Photo: Edgar Bernard, Inmaculada Fortanet, Noelia Ruiz i Julia Valeiras. The Research Group on Academic and Professional English at the Universitat Jaume I (GRAPE-UJI) is developing a computer tool to ...

Paradigm, one of the largest venture investors focused on crypto, is expanding its brief to include artificial intelligence, robotics and other forms of frontier-tech, according to people familiar ...

Paradigm's Matt Huang previously said developments in AI were "too interesting to ignore" and that both AI and crypto will have plenty of overlap. Crypto investment firm Paradigm is seeking to raise ...

Tech-enabled clinical research platform Paradigm Health has secured $78 million in an oversubscribed Series B financing round and announced its acquisition of oncology-focused digital health company ...

Paradigm Health has raised $78 million as it works to revamp the clinical research ecosystem, while also announcing a deal to acquire Flatiron Health's clinical research business unit. With the ...

Thirty years ago today, Netscape Communications and Sun Microsystems issued a joint press release announcing JavaScript, an object scripting language designed for creating interactive web applications ...

Matthew Herper covers medical innovation — both its promise and its perils. When people talk about using artificial intelligence to transform the way medicines are studied, they often imagine ...